At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LABU Direxion Daily S&P Biotech Bull 3x Shares
Post-Mkt 03-16 16:51:00 EDT
156.24
+7.39
+4.96%
盘后156.24
+0.000.00%
16:41 EDT
High158.64Low153.48Vol570.53K
Open153.69D1 Closing148.85Amplitude3.46%
Mkt Cap503.79MTradable Cap503.79MTotal Shares3.22M
T/O89.35MT/O Rate17.69%Tradable Shares3.22M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS) and Olema Pharmaceuticals (OLMA)
TIPRANKS  ·  02:00
Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS) and Olema Pharmaceuticals (OLMA)
NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug
Benzinga_recent_news  ·  01:35
NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug
Buy Rating on BioMarin: Strong Early Voxzogo Data, Real‑World Durability, and Underpenetrated Achondroplasia Opportunity Drive Upside
TIPRANKS  ·  01:25
Buy Rating on BioMarin: Strong Early Voxzogo Data, Real‑World Durability, and Underpenetrated Achondroplasia Opportunity Drive Upside
Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS) and Aprea Therapeutics (APRE)
TIPRANKS  ·  00:40
Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS) and Aprea Therapeutics (APRE)
GE Healthcare’s LUMINA Trial Positions New MRI Contrast Agent for Future Growth
TIPRANKS  ·  00:31
GE Healthcare’s LUMINA Trial Positions New MRI Contrast Agent for Future Growth
Health Care Roundup: Market Talk
Dow Jones  ·  00:20
Health Care Roundup: Market Talk
De-Risked Path to Market and Concentrated Rare Disease Opportunity Support Buy Rating on Savara’s Molbreevi
TIPRANKS  ·  03-16 23:35
De-Risked Path to Market and Concentrated Rare Disease Opportunity Support Buy Rating on Savara’s Molbreevi
Fidia Advances POC Financing with New Share Issue to GGHL
TIPRANKS  ·  03-16 23:34
Fidia Advances POC Financing with New Share Issue to GGHL
Fortis Healthcare Reports No Requests Under SEBI Physical Share Transfer Window
TIPRANKS  ·  03-16 22:33
Fortis Healthcare Reports No Requests Under SEBI Physical Share Transfer Window
Analysts Are Bullish on These Healthcare Stocks: Beam Therapeutics (BEAM), Pelthos Therapeutics (PTHS)
TIPRANKS  ·  03-16 21:50
Analysts Are Bullish on These Healthcare Stocks: Beam Therapeutics (BEAM), Pelthos Therapeutics (PTHS)
Novartis Advances Dermatology Portfolio With Cosentyx FDA Approval For Pediatric Patients
Benzinga  ·  03-16 21:42
Novartis Advances Dermatology Portfolio With Cosentyx FDA Approval For Pediatric Patients
Assessing Vera Therapeutics (VERA) Valuation As Deerfield Ups Stake And FDA Priority Review Nears
Simply Wall St.  ·  03-16 21:10
Assessing Vera Therapeutics (VERA) Valuation As Deerfield Ups Stake And FDA Priority Review Nears
Sector Update: Health Care
MT Newswires Live  ·  03-16 21:02
Sector Update: Health Care
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Stevanato Group (STVN) and BioNTech SE (BNTX)
TIPRANKS  ·  03-16 20:40
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Stevanato Group (STVN) and BioNTech SE (BNTX)
Press Release: LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team
Dow Jones  ·  03-16 20:01
Press Release: LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team
Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
GlobeNewswire  ·  03-16 20:00
Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO) and Tonix Pharma (TNXP)
TIPRANKS  ·  03-16 19:30
Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO) and Tonix Pharma (TNXP)
Elizabeth Warren Says 'Hard No' To Trump's $50 Billion Iran War Funding Request: Congress 'Could Afford' Health Care Tax Credits Instead
Benzinga  ·  03-16 19:13
Elizabeth Warren Says 'Hard No' To Trump's $50 Billion Iran War Funding Request: Congress 'Could Afford' Health Care Tax Credits Instead
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer
GlobeNewswire  ·  03-16 19:00
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer
Yestar Healthcare Sets March 2026 Board Meeting to Review 2025 Results and Dividend
TIPRANKS  ·  03-16 17:45
Yestar Healthcare Sets March 2026 Board Meeting to Review 2025 Results and Dividend

Introduction

Company Name.
Direxion Daily S&P Biotech Bull 3x Shares
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Issue price:
--